Following another rough quarter, NeuroMetrix has sought outside help in an effort to restructure its business and is pivoting away from a direct-to-consumer business model for its wearable pain relief platform, Quell.
“NeuroMetrix has good product lines and technology, and more broadly, the company has real value,” Dr. Shai Gozani, CEO and president of NeuroMetrix, told investors in a recent...
Laid to rest. A longstanding legal dispute between Apple and Valencell over infringement on four patents and deceptive trade practices was quietly put to bed last year. The two companies submitted their dismissal to the US District Court North Carolina in September, with no other details on how the settlement shook out.
When this case (and a similar one against Fitbit) was first filed in early...
The end of an error. The Wall Street Journal reports that Theranos, the once-promising blood testing startup now plagued by scandals and lawsuits, will soon be shutting its doors for good. In a letter to shareholders obtained by the Journal, CEO and General Counsel David Taylor wrote that the company’s attempts to negotiate a sale transaction did not bear fruit, and that the company is in default...
Earnings reports shared by neurostimulation and digital medicine company NeuroMetrix during a Q2 investors’ call showed a slight drop in total revenue as the company is preparing to place its marketing weight behind the launch of its updated wearable pain relief product, Quell. However, the company remained profitable during the quarter thanks to sales of its other product, DPNCheck.
Dr. Shai N....
SPR Therapeutics, the Cleveland, Ohio-based developer of a wearable pain management device, announced yesterday the completion of $25 million in Series C financing. The company’s new funding — primarily secured from Frontcourt Ventures and an unnamed family office — will support commercialization of the Sprint Peripheral Nerve Stimulation System, and investigate its applicability across...
In addition to the many device launches, several digital health companies use CES (formerly known as the Consumer Electronic Show) in Las Vegas as an opportunity to announce updates and major partnerships and collaborations. Read on for the biggest non-launch health news from the show.
Lots of news from Fitbit
Wearable giant Fitbit announced a number of partnerships as well as updates to its app...
Target has plans to launch a new digital health initiative next month online and in 500 of its 1,793 stores. Beyond knowing the stories will offer a new section for health devices, details on what, exactly, the launch will entail are scarce. One device that will be included is Quell, an FDA-cleared and smartphone-connected wearable for treating chronic pain from Waltham, Massachusetts-based...
Neurometrix has received FDA clearance for a new smartphone-controlled version of Quell, its wearable for pain relief, the company announced last week.
Like its predecessor, the device will use nerve stimulation to treat chronic pain by sending signals to the brain that cause it to release natural opioids. It's worn around the calf.
“This 510(k) further advances Quell technology by allowing the...
By: The MobiHealthNews Team
By the end of CES15 MobiHealthNews has tracked more than 40 health device makers who either unveiled or launched products, announced updated pricing or new features for already known ones. If you missed our first roundup of health devices from CES15 -- be sure to check them out here. Read on for another 19 digital health device makers who made news at CES15 in Las...
